Sukhatme Mayukh (CIK 1750050) reported 31 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-21). Recent activity: Buy ROIV (172,899 shares), Sell ROIV (172,899 shares), Buy ROIV (17,519 shares), Sell ROIV (17,519 shares), Buy ROIV (144,756 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-21 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 172,899 | $665,661 |
| 2026-08-21 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 172,899 | $6.4M |
| 2026-08-21 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 17,519 | $67,448 |
| 2026-08-21 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 17,519 | $653,459 |
| 2026-08-21 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 144,756 | $557,311 |
| 2026-08-21 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 144,756 | $5.3M |
| 2026-08-18 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 31,801 | $122,434 |
| 2026-08-18 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 243,177 | $8.8M |
| 2026-08-18 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 284,707 | $1.1M |
| 2026-08-18 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 284,707 | $10.3M |
| 2026-08-18 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 105,141 | $404,793 |
| 2026-08-18 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 105,141 | $3.8M |
| 2026-08-18 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 243,177 | $936,231 |
| 2026-08-18 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 31,801 | $1.2M |
| 2026-07-02 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 46,878 | $1.7M |
| 2026-06-29 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 500,000 | $1.9M |
| 2026-06-29 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 500,000 | $17.1M |
| 2026-06-29 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 500,000 | $1.9M |
| 2026-06-29 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 500,000 | $17.0M |
| 2026-02-11 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 651,558 | $8.3M |
| 2026-02-11 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 339,441 | $9.0M |
| 2026-02-11 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 312,117 | $8.3M |
| 2025-12-31 | Roivant Sciences Ltd. (ROIV) | President & CIO | Buy | 748,358 | $9.5M |
| 2025-12-31 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 311,873 | $6.8M |
| 2025-12-31 | Roivant Sciences Ltd. (ROIV) | President & CIO | Sell | 436,485 | $9.5M |
Source: SEC Form 4 filings · as of 2026-08-21